Literature DB >> 31262517

The cytotoxic effect of oxymatrine on basic cellular processes of A549 non-small lung cancer cells.

Magdalena Izdebska1, Wioletta Zielińska2, Marta Hałas-Wiśniewska2, Klaudia Mikołajczyk2, Alina Grzanka2.   

Abstract

Oxymatrine is the alkaloid derived from the root of Sophora species. This compound is proven to exhibit anti-viral, anti-asthmatic, anti-fibrotic and anti-inflammatory properties. Additionally, oxymatrine is able to promote cancer cells apoptosis and inhibit their proliferation. The aim of this study was to present the influence of oxymatrine on non-small cell lung cancer cells. The results indicate, that this agent induces dose-dependent cell death mainly through ER stress-induced apoptosis pathway. We also suggest that the oxymatrine reduces the metastatic potential by inhibition of the EMT process, as A549 cells treated with chosen doses of the compound were characterized by a decrease in the expression of the N-cadherin, vimentin and the elevation of E-cadherin level. Moreover, the study broadens the knowledge on so far poorly understood aspect of the influence of oxymatrine on the cytoskeleton structure.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  A549 cell line; cytoskeleton; epithelial-mesenchymal transition; non-small cell lung cancer; oxymatrine

Year:  2019        PMID: 31262517     DOI: 10.1016/j.acthis.2019.06.008

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  2 in total

Review 1.  Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives.

Authors:  Howaida I Abd-Alla; Dalila Souguir; Mohamed O Radwan
Journal:  Arch Pharm Res       Date:  2021-12-15       Impact factor: 4.946

2.  A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion.

Authors:  Jian Guo; Huating Zeng; Xinmeng Shi; Tao Han; Yimin Liu; Yuping Liu; Congyan Liu; Ding Qu; Yan Chen
Journal:  J Nanobiotechnology       Date:  2022-03-05       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.